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Abstract 1 
Autophagy plays a critical role in immunity by directly degrading invading pathogens such as 2 
Group A Streptococcus (GAS), a process that has been named xenophagy. We previously 3 
demonstrated that autophagic vacuoles directed against GAS, termed GAS-containing 4 
autophagosome-like vacuoles (GcAVs), use recycling endosomes (REs) as a membrane source. 5 
However, the precise molecular mechanism that facilitates the fusion between GcAVs and REs 6 
remains unclear. Here, we demonstrate that STX6 (syntaxin 6) is recruited to GcAVs and forms 7 
a complex with VTI1B and VAMP3 to regulate the GcAV-RE fusion that is required for 8 
xenophagy. STX6 targets the GcAV membrane through its tyrosine-based sorting motif and 9 
transmembrane domain, and localizes to TFRC (transferrin receptor)-positive punctate 10 
structures on GcAVs through its H2 SNARE domain. Knockdown and knockout experiments 11 
revealed that STX6 is required for the fusion between GcAVs and REs to promote clearance of 12 
intracellular GAS by autophagy. Moreover, VAMP3 and VTI1B interact with STX6 and 13 
localize on the TFRC-positive puncta on GcAVs, and are also involved in the RE-GcAV fusion. 14 
Furthermore, knockout of RABGEF1 impairs the RE-GcAV fusion and STX6-VAMP3 15 
interaction. These findings demonstrate that RABGEF1 mediates RE fusion with GcAVs 16 
through the STX6-VAMP3-VTI1B complex, and reveal the SNARE dynamics involved in 17 
autophagosome formation in response to bacterial infection. 18 
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Introduction 1 
Autophagy is a lysosomal degradation pathway that degrades cytoplasmic components, 2 
including protein aggregates, damaged organelles, and invading bacteria. This pathway is 3 
essential for cellular homeostasis, survival, development, and host defense. During autophagy, 4 
a flat membrane structure, called the isolation membrane, is generated from or close to the 5 
endoplasmic reticulum and surrounds a portion of the cytoplasmic content and forms a closed 6 
double-membrane structure, the autophagosome. The process of autophagosome formation is 7 
regulated by autophagy-related (Atg) proteins, and one of the Atg proteins, LC3 (mammalian 8 
homolog of Atg8 in yeast), specifically localizes on autophagosomes; the autophagosomes 9 
subsequently fuse with lysosomes and form the autolysosome, a lysosomal vacuole in which 10 
the autophagosome contents are degraded.1, 2 11 
 Autophagy not only degrades a cell’s own components, but also targets invading 12 
microbial pathogens. This antimicrobial autophagy, which is named xenophagy,3, 4 has been 13 
recognized as a crucial intracellular immune system against various pathogens, such as 14 
Salmonella Typhimurium and Group A Streptococcus (GAS).4, 5 GAS, one of the major 15 
human pathogens, enters epithelial cells through endocytosis and then escapes into the 16 
cytoplasm by secreting streptolysin O, a pore-forming toxin produced by GAS.6 The exposed 17 
GAS in the cytoplasm is recognized by the ubiquitin and adaptor proteins SQSTM1/p62 and 18 
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CALCOCO2/NDP52 pathway and entrapped by an LC3-positive autophagic membrane 1 
structure, the GAS-containing autophagosome-like vacuole (GcAV). RAB7 and RAB9A 2 
facilitate the homotypic fusion between GcAVs that generates large GcAVs,7, 8 and RAB9A 3 
mediates the fusion of GcAVs with lysosomes, which results in the degradation of the 4 
entrapped bacteria.8 Recently, we showed that forming (unclosed) GcAV membranes contain 5 
punctate structures that are derived from recycling endosomes (REs).9 Moreover, we found 6 
that RAB17-mediated RE recruitment into GcAVs promoted the formation of GcAVs and the 7 
elimination of intracellular bacteria, which suggested that the RE functions as a primary 8 
membrane source for—and is critical for—autophagosome formation during xenophagy.9 9 
However, the mechanism of RE fusion with GcAVs remains unclear, and elucidation of this 10 
mechanism is crucial for understanding xenophagy. 11 
 Specific membrane-fusion events in diverse vesicle-mediated transport pathways 12 
are typically regulated by soluble N-ethylmaleimide-sensitive factor attachment protein 13 
receptor (SNARE) complexes.10 At the membrane-fusion step, the SNARE complex forms 14 
parallel 4-helix bundles comprising the Qa-, Qb-, Qc-, and R-SNAREs. To date, several 15 
SNAREs have been shown to function in autophagy in mammals: STX17 (syntaxin 17), 16 
SNAP-29, VAMP8, VTI1B, and VAMP7 are required for lysosome-autophagosome fusion,11, 17 
12 and VAMP8 and VTI1B are also used in GcAV-lysosome fusion.12 Furthermore, in yeast, 18 
Vam3, Vam7, Ykt6, and Vti1 have been identified to regulate lysosomal fusion.13, 14 With 19 
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regard to the autophagosome formation process preceding lysosomal fusion, previous studies 1 
have reported that VAMP3 mediates heterotypic fusion between ATG9- and 2 
ATG16L1-positive vesicles for autophagosome precursor formation,15 and that yeast Sec22, 3 
Ykt6, Tlg2, Sec9, and Sso1 are required for isolation membrane biogenesis.16 Thus, 4 
identifying the SNARE complex that functions in the RE-autophagosome fusion step is 5 
critical for understanding not only xenophagy, but also the fundamental autophagosome 6 
formation mechanism in mammals. 7 
 In this study, to identify the SNARE complex that is involved in 8 
RE-autophagosome fusion during bacterial infection, we examined the subcellular 9 
localization of STX-family proteins during GAS infection. We report that STX6 localizes to 10 
RE-derived punctate structures on GcAVs and is recruited to GcAVs in response to GAS 11 
infection, and that STX6 knockout impairs RE recruitment to GcAVs and suppresses GcAV 12 
formation. Furthermore, we show that VAMP3 and VTI1B function together with STX6 in 13 
RE-GcAV fusion. 14 
  15 
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Results 1 
STX6 localizes to TFRC-positive puncta on GcAVs during GAS infection 2 
To identify the SNARE proteins that mediate RE-GcAV fusion, we examined the localization 3 
of EmGFP-fused STX proteins and the autophagosomal marker MAP1LC3B/LC3B during 4 
GAS infection in HeLa cells. Out of 11 STX proteins, 5 (STX6, STX10, STX11, STX12, and 5 
STX17) were found to clearly colocalize with GAS-surrounding LC3-positive vacuoles 6 
(GcAVs) (Fig. S1). We counted the EmGFP-STX-positive GcAVs and determined that 7 
EmGFP-STX6 most frequently colocalized with GcAVs (61.5% ± 5.8%) (Fig. 1A). To 8 
confirm the GcAV localization of STX6, we examined the subcellular localization of 9 
endogenous STX6 during GAS infection. STX6 was detected around GAS and colocalized 10 
with GcAVs (Fig. 1B). Furthermore, EmGFP-STX6 showed punctate localization on forming 11 
(unclosed) GcAVs (Fig. 1C), and the GcAV colocalization frequency increased with time after 12 
infection (Fig. 1D). Next, we examined STX6 colocalization with TFRC, an RE marker, in 13 
GAS-infected cells, and found that EmGFP-STX6 clearly colocalized with TFRC on GcAVs 14 
(Fig. 1E). To determine whether STX6 preferentially colocalizes with TFRC on GcAVs, we 15 
calculated the Pearson’s coefficient for colocalization from the GcAV images: STX6 showed 16 
significantly higher colocalization with TFRC than with LC3 on GcAVs (Fig. 1F). 17 
Furthermore, the signal-intensity plot (Fig. 1G) of STX6 and TFRC together with GcAVs (red 18 
line in the figure) revealed coincident signal peaks (orange arrows). These results demonstrate 19 
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that STX6 colocalizes with TFRC-positive punctate structures on GcAVs. We also performed 1 
time-lapse imaging of cells during GAS infection and examined EmGFP-STX6 recruitment 2 
into GcAVs. We found that bacteria-containing LC3-positive vacuoles acquired punctate 3 
EmGFP-STX6 with time (Fig. 1H), indicating that STX6 is recruited to autophagosomes 4 
during GAS infection. 5 
 6 
STX6 is involved in RE-GcAV fusion 7 
Because STX6 localized to TFRC-positive puncta on GcAVs, we next knocked down STX6 8 
expression (Fig. 2A) and determined whether STX6 is required for RE-GcAV fusion and 9 
GcAV formation: STX6 knockdown led to a reduction in TFRC-positive GcAVs (Fig. 2B and 10 
2C). We also constructed an STX6-knockout HeLa cell line by using the CRISPR/Cas9 11 
genome-editing system (Fig. 2D),17 and found that in these STX6-knockout cells, the TFRC 12 
signal was rarely detected on GcAVs (Fig. 2E and 2F). Furthermore, in rescue experiments, 13 
FLAG-STX6 expression in the STX6-knockout HeLa cells increased RE recruitment to 14 
GcAVs (Fig. 2F). To investigate the effects of STX6 knockout on transferrin uptake and the 15 
endocytosis pathway associated with TFRC, we treated cells with Alexa-594-labelled human 16 
transferrin and observed internalized transferrin, and also examined the subcellular 17 
localization of TFRC in STX6-knockout cells. In our experiments, transferrin was normally 18 
internalized (Fig. S2A), and TFRC frequently colocalized with RAB17 in the perinuclear 19 
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region and partially overlapped with TGOLN2/TGN46 (TGN marker) in STX6-knockout 1 
cells (Fig. S2B and S2C). These knockdown and knockout results clearly demonstrate that 2 
STX6 functions in RE-GcAV fusion. 3 
 RE recruitment to GcAVs involves RAB17 and RABGEF1, and RAB17 4 
inactivation reduces GcAV formation; these findings indicate that REs promote GcAV 5 
formation. Thus, to determine whether STX6-mediated RE fusion is involved in GcAV 6 
formation, we quantified GcAV formation efficiency in wild-type and STX6-knockout HeLa 7 
cells: The characteristic large GcAVs were detected only in wild-type cells (Fig. 2G), and 8 
significantly fewer STX6-knockout cells were GcAV-positive as compared to wild-type cells 9 
(Fig. 2H). To ascertain whether or not the defective autophagosome formation in 10 
STX6-knockout cells affects the viability of intracellular GAS, we determined the number of 11 
surviving GAS. Although the number of invaded GAS was not altered, the number of 12 
recovered GAS at 4 h after infection significantly increased in STX6-knockout cells 13 
compared with wild-type cells (Fig. 2I). Collectively, our results suggest that RE-GcAV 14 
fusion involves STX6 and that this STX6-mediated fusion facilitates GcAV formation to 15 
restrict GAS proliferation in cells. 16 
 17 
VAMP3 and VTI1B function together with STX6 18 
Next, we searched for other SNARE proteins that function in the RE-GcAV fusion step 19 
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together with STX6. Previously, STX6 was found to associate with various SNARE proteins, 1 
such as VAMP7, VAMP8, VTI1A, and VTI1B, and was suggested to interact with distinct 2 
SNARE partners depending on the cell type examined.18 Therefore, we screened for the 3 
SNARE proteins that localized to TFRC-positive puncta on GcAVs in HeLa cells; our results 4 
showed that 6 SNARE proteins colocalized with GcAVs (Fig. S3), and 2 of these proteins, 5 
VAMP3 and VTI1B, preferentially colocalized with TFRC on GcAVs, but not with LC3 on 6 
GcAVs (Fig. 3A–3C). Furthermore, immunoprecipitation analyses revealed that STX6 7 
interacts with VAMP3 and VTI1B during GAS infection (Fig. 3D). 8 
To ascertain whether VAMP3 and VTI1B facilitate the fusion between REs and 9 
GcAVs, we knocked down the expression of these SNARE proteins (Fig. 3E). VAMP3 10 
knockdown inhibited the Golgi-like perinuclear compartment localization of transferrin (Fig. 11 
S4A). In contrast, VAMP3 and VTI1B knockdown did not affect transferrin uptake or 12 
colocalization between TFRC and RAB17 (Fig. S4A and S4B), suggesting that it did not 13 
profoundly affect RAB17-associated TFRC trafficking. However, knockdown of either 14 
VAMP3 or VTI1B significantly reduced the colocalization of TFRC and GcAVs (Fig. 3F and 15 
3G). Collectively, these results suggest that VAMP3 and VTI1B cooperate with STX6 in the 16 
RE-GcAV fusion process. 17 
 18 
H2 SNARE domain of STX6 is required for punctate localization on GcAVs and interaction 19 
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with VAMP3 and VTI1B 1 
We next sought to identify the domains of STX6 that are responsible for its localization to 2 
GcAVs and the TFRC-positive punctate structures on GcAVs. The STX6 gene encodes a 3 
protein containing 255 amino acids, and the C-terminal 20 amino acids of STX6 are 4 
hydrophobic and form a transmembrane (TM) domain.18 STX6 further contains 2 coiled-coil 5 
domains—H1 and H2—that have been implicated in mediating protein interactions,18 and one 6 
tyrosine-based sorting motif (YGRL, residues 140–143). We constructed STX6 deletion 7 
mutants lacking the aforementioned domains (Fig. 4A) and quantified their GcAV 8 
colocalization in HeLa cells. Deletion of the TM domain suppressed STX6 targeting to all 9 
membranes, including GcAVs (Fig. 4B and 4C), which suggests that the TM domain is 10 
necessary for GcAV localization of STX6. Moreover, although STX6 166–255 and ΔYGRL 11 
mutants appeared to retain their intracellular membrane localization, they also failed to 12 
localize to GcAVs (Fig. 4B and 4C). These results suggest that the YGRL sorting motif is 13 
required for GcAV targeting. Intriguingly, EmGFP-STX6 ΔH2 was detected on GcAVs but 14 
did not display the punctate localization, and this mutant showed higher colocalization with 15 
LC3 than did wild-type STX6 (Fig. 4B and 4C). Additionally, the signal peaks of 16 
EmGFP-STX6ΔH2 did not coincide with those of TFRC on GcAVs (Fig. 4D). These results 17 
suggest that the H2 domain is required for the TFRC-positive punctate localization of STX6 18 
on GcAVs. 19 
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The H2 domain is also known as the SNARE core domain, and thus we performed 1 
immunoprecipitation assays by using the STX6 deletion mutants to examine the domain’s role 2 
in STX6 interactions: VAMP3 precipitated with STX6 wild-type and ΔH1 but not ΔH2 (Fig. 3 
4E), which suggested that the STX6 H2 domain interacts with VAMP3. Similarly, STX6 ΔH2 4 
did not interact with VTI1B (Fig. 4E). To determine whether the H2 domain and YGRL motif 5 
are required for GcAV formation, we performed rescue experiments using these deletion 6 
constructs. Expression of full-length STX6 recovered GcAV formation efficiency in 7 
STX6-knockout cells, and this recovery was not observed in ΔH2 or ΔYGRL mutants (Fig. 8 
4F). Taken together, our findings suggest that STX6 is recruited to GcAVs by the YGRL 9 
sorting motif and is localized in the membrane through its TM domain, and further that STX6 10 
exhibits a punctate localization and interacts with other SNARE proteins through the H2 11 
SNARE domain. 12 
 13 
RABGEF1 is required for STX6-mediated RE-GcAV fusion 14 
We previously reported that RAB17 and RABGEF1 regulate RE recruitment into GcAVs and 15 
GcAV formation and thereby facilitate xenophagy.9 In the present study, we investigated 16 
whether the STX6/VAMP3/VTI1B complex colocalizes with RAB17-positive vesicles. 17 
EmGFP-STX6 and -VAMP3 colocalized with mCherry-RAB17 in the perinuclear region and 18 
in many vesicles; however, VTI1B only colocalized with RAB17 in the perinuclear region 19 
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(Fig. S5). Thus, to determine whether RAB17/RABGEF1 and the STX6/VAMP3/VTI1B 1 
complex function in same pathway during GcAV formation, we generated a 2 
RABGEF1-knockout HeLa cell line (Fig. 5A) and analyzed the involvement of the 3 
STX6-VAMP3-VTI1B complex. First, we examined the colocalization of LC3 and TFRC 4 
during GAS infection, and found that the colocalization between GcAVs and TFRC was 5 
decreased in RABGEF1-knockout cells (Fig. 5B and 5C); furthermore, GcAV formation 6 
efficiency was also reduced in the knockout cells (Fig. 5D). Expression of RABGEF1 7 
increased the numbers of both TFRC-positive GcAV and GcAV-positive cells among 8 
RABGEF1-knockout cells (Fig. 5B-5D), confirming that RABGEF1 facilitates RE-GcAV 9 
fusion and GcAV formation. These results agreed with the findings of our previous study.9 10 
Next, we analyzed the effects of RABGEF1 knockout on the GcAV localization of STX6, 11 
VAMP3, and VTI1B. Whereas EmGFP-STX6 and -VTI1B were detected on GcAVs at similar 12 
levels in wild-type and RABGEF1-knockout cells, EmGFP-VAMP3-positive GcAVs were 13 
rarely observed in the knockout cells (Fig. 5E). Quantification of the colocalization between 14 
EmGFP-SNAREs and GcAVs revealed that the colocalization of VAMP3 with GcAVs was 15 
substantially lower in RABGEF1-knockout cells than in control cells (Fig. 5F). These data 16 
suggest that VAMP3 recruitment to GcAVs is regulated by RABGEF1.  17 
Furthermore, to ascertain whether STX6-VAMP3-VTI1B interactions are also 18 
regulated by RABGEF1, we performed immunoprecipitations with the RABGEF1-knockout 19 
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cells. Although the interaction between STX6 and VTI1B was almost equal in control and 1 
knockout cells, the association between STX6 and VAMP3 was substantially decreased in 2 
RABGEF1-knockout cells (Fig. 5G and 5H), which indicates that RABGEF1 is required for 3 
the interaction between STX6 and VAMP3. Collectively, these results suggest that VAMP3 is 4 
recruited to GcAVs through a RABGEF1-mediated pathway and forms a complex with STX6 5 
and thus mediates RE-GcAV fusion. 6 
 7 
STX6 but not RABGEF1 is involved in starvation-induced autophagosome formation 8 
Lastly, we examined the involvement of STX6 and RABGEF1 in autophagy during starvation. 9 
LC3-II levels increased under starvation or treatment with protease inhibitors (E64d and 10 
pepstatin A) in wild-type cells; however, STX6 knockout suppressed LC3-II accumulation 11 
under starvation and protease inhibitors treated conditions (Fig. 6A and 6B). This suggests 12 
that autophagosome formation was impaired. In contrast, the LC3-II level increased in 13 
response to starvation in RABGEF1-knockout cells (Fig. 6C and 6D), suggesting that 14 
RABGEF1 is dispensable for starvation-induced autophagosome formation.  15 
 In wild-type cells, the number of GFP-LC3 puncta increased during starvation (Fig. 16 
6E and 6F). The number of GFP-LC3 puncta also increased slightly even in STX6-knockout 17 
cells; however, the number was still significantly lower than that in wild-type cells (Fig. 6E 18 
and 6F). Taken together, these findings suggest that STX6 but not RABGEF1 is involved in 19 
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autophagosome formation under starvation conditions. 1 
 2 
Discussion  3 
In this study, we showed that STX6 regulates the fusion between autophagosomes and REs 4 
and thereby promotes autophagosome biogenesis during xenophagy. STX6 targets the 5 
GAS-capturing, forming (unclosed) GcAVs through its tyrosine-based sorting motif and 6 
localizes to RE-derived punctate structures on GcAVs. VTI1B and VAMP3 also localize to 7 
this punctate structure, and the recruitment of VAMP3 depends on a RABGEF1-mediated 8 
RE-GcAV fusion pathway. Notably, the results of knockdown and knockout analysis showed 9 
that the STX6-VAMP3-VTI1B complex is required for the GcAV-RE fusion and GcAV 10 
formation necessary for xenophagy. 11 
 STX6 is widely recognized to participate in various fusion events.18 However, this 12 
is the first report of STX6 involvement in autophagy. STX6 mainly localizes to the 13 
trans-Golgi network (TGN) and endosomal structures, and is suggested to regulate Glut4 14 
trafficking,19 the secretory pathway,20 caveolar endocytosis,21 and endosome-TGN retrograde 15 
transport.22 TFRC-positive REs are also incorporated into starvation-induced autophagosomes 16 
and facilitate autophagosome formation, and their trafficking is regulated by TBC1D14 and 17 
RAB11.23 However, the fusion of REs with GcAVs is mediated by RAB17 rather than 18 
RAB11,9 and thus the SNARE machinery involved in the RE-autophagosome fusion step 19 
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might also differ between canonical autophagy and xenophagy. 1 
 We revealed the GcAV localization of STX6 in this study and identified the STX6 2 
domains required for the protein’s targeting to and punctate localization on GcAVs. Because 3 
the number of STX6-positive GcAVs increased with time, STX6 is likely acquired by GcAVs 4 
and not initially contained in GcAV precursors. Notably, deletion of the tyrosine-based motif 5 
YRGL in STX6 prevented the recruitment of STX6 to GcAVs (Fig. 4B and 4C). The YGRL 6 
motif of STX6 functions in the return to the trans-Golgi from the plasma membrane,24 and it 7 
is also required for targeting to the chlamydia inclusion membrane.25, 26 Kabeiseman et al. 8 
suggested that deletion or alteration of the YGRL region does not markedly affect the protein 9 
interactions of STX6, but reduces the interaction with lipids such as phosphatidylinositol 10 
3-phosphate, phosphatidylinositol 4-phosphate, and phosphatidylinositol 5-phosphate.26 11 
Therefore, although it is not yet clear whether STX6 is recruited to GcAVs through lipid 12 
interactions, further investigation of the lipid contents of GcAVs should help enhance our 13 
understanding of STX6 recruitment. 14 
We found that STX6 forms a complex with VTI1B and VAMP3 and that this 15 
complex defends cells through autophagy. Interestingly, STX6 and VTI1B have been reported 16 
to function as a part of the Q-SNARE complex (STX6-VAMP7-VTI1B) on the TGN together 17 
with the R-SNARE VAMP3 and thereby regulate TNFα trafficking in macrophages.27 18 
Moreover, the STX6-VTI1B-VAMP3 complex has been reported to regulate the IL-6 19 
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secretion pathway through REs in macrophages.28 Because STX6 is suggested to change its 1 
SNARE partners and thus specifically regulate several different fusion events, the 2 
STX6-VTI1B-VAMP3 complex could be activated in response to pathogenic infection. 3 
Intriguingly, STX6 is a cholesterol-binding protein,29 and alteration of the cholesterol level at 4 
the TGN/endosome boundary causes STX6 accumulation on VAMP3-positive REs.30 5 
Bacterial pathogens carry secreted toxins that interact with cholesterol and affect its 6 
intracellular balance,31, 32 and streptolysion O, a cytolysin secreted by GAS, also interacts 7 
with cholesterol molecules in target bilayers and could affect cholesterol dynamics.33 This 8 
raises the possibility that the STX6-VAMP3-VTI1B complex is activated in response to 9 
changes in cholesterol levels during bacterial infection. 10 
VTI1B has been reported to be involved in the fusion between GcAVs and 11 
lysosomes, which suggests that VTI1B regulates multiple steps of the GcAV formation 12 
process. Furuta et al.12 reported that VTI1B is recruited to GcAVs before lysosomal fusion, 13 
and our results also showed that VTI1B colocalized with forming (unclosed) GcAVs (Fig. 3C). 14 
However, VTI1B mainly localizes in the TGN and endosomes34 and is recruited to GcAVs 15 
even in RABGEF1-knockout cells; thus, we suggest that VTI1B targets GcAVs through a 16 
pathway distinct from that used by VAMP3. 17 
Although this finding is slightly out of the scope of the present study, we found that 18 
STX6 is required for autophagosome formation under starvation conditions (Fig. 6A, 6B, 6E 19 
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and 6F). Importantly, RABGEF1 was dispensable for starvation-induced autophagosome 1 
formation (Fig. 6C and 6D), in agreement with our previous data. Because STX6-mediated 2 
RE fusion involves RABGEF1, STX6 might be involved in canonical autophagy through a 3 
mechanism different from that involved in xenophagy. Zhang et al. reported that O-linked 4 
β-N-acetylglucosamine transferase modifies the SNARE protein SNAP-29 in a 5 
nutrient-dependent manner and implied that the STX6-SNAP-29 complex is involved in 6 
autophagy induction.35, 36 Considering our results regarding starvation-induced autophagy, 7 
STX6 may be an essential regulator in canonical autophagy. 8 
In this study, we showed that GcAV localization was exhibited by 11 SNAREs 9 
(EmGFP-fused STX6, STX10, STX11, STX12, STX17, VAMP2, VAMP3, VAMP4, VAMP7, 10 
VAMP8, and VTI1B), but roles in GcAV formation have been identified for only 5 of these 11 
SNAREs; we have described the function of STX6. Our finding that several SNAREs localize 12 
on GcAVs suggests the involvement of multiple organelle-derived vesicles in GcAV 13 
formation, but the functions of other SNAREs in xenophagy remain unclear. Additional 14 
studies on SNAREs will not only help reveal the molecular mechanism of GcAV formation, 15 
but also enhance our understanding of canonical autophagy. 16 
  17 
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Materials and Methods 1 
Cell culture and transfection 2 
HeLa cells were maintained in Dulbecco’s modified Eagle’s medium (DMEM; Nacalai 3 
Tesque, 18459-64) supplemented with 10% fetal bovine serum (FBS; Gibco) and 50 µg/mL 4 
gentamicin (Nacalai Tesque, 11980-14) in a 5% CO2 incubator at 37°C. The transfection 5 
reagents used were polyethylenimine (Polysciences, 23966-2) and Lipofectamine 3000 6 
(Invitrogen Corporation, L3000001). 7 
Bacterial strain 8 
GAS strain JRS4 (M6+ F1+) was grown in Todd-Hewitt broth (BD Diagnostic Systems) 9 
supplemented with 0.2% yeast extract (THY) as described previously.6 10 
Antibodies and other reagents 11 
The following primary antibodies were used: rabbit monoclonal anti-Syntaxin 6 (C34B2; 12 
2869), rabbit polyclonal anti-VAMP3 (13640), rabbit monoclonal anti-β-actin (D6A8; 8457), 13 
and rabbit monoclonal anti-RABGEF1 for Rabex5 (D21F12; 7622), from Cell Signaling 14 
Technology; rabbit polyclonal anti-VTI1B (Proteintech Group, 14495-1-AP); mouse 15 
monoclonal anti-CD71 (OX26) for TFRC (Santa Cruz Biotechnology, sc-53059); mouse 16 
monoclonal anti-FLAG (M2) (Sigma-Aldrich, A2220); and mouse monoclonal anti-GFP 17 
(GF200), (Nacalai Tesque, 04363-24). The secondary antibodies used were the following: for 18 
immunoblotting, HRP-conjugated anti-rabbit and anti-mouse IgG (Jackson ImmunoResearch 19 
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Laboratories, 111-035-144 and 115-035-003 respectively); for immunostaining, Cy5-goat 1 
anti-rabbit IgG (Jackson ImmunoResearch Laboratories, 711-175-152), and anti-mouse or 2 
anti-rabbit IgG conjugated with AlexaFluor-488/-594 (Invitrogen Corporation, A-11001, 3 
A-11008, A-11032, and A-21442). E64d (Enzo Life Sciences, BML-PI107-0001) and 4 
pepstatin A (Nacalai Tesque, 26305-03-3) were used at 10 µg/mL and 30 µg/mL, 5 
respectively. 6 
Plasmids 7 
Human SNARE cDNAs were PCR-amplified from HeLa, KYSE, and HEK293T cell total 8 
mRNAs and cloned into pcDNA-6.2/N-EmGFP-DEST (N-terminal tagged), 9 
pcDNA-6.2/N-3xFLAG-DEST (N-terminal tagged), and pcDNA-6.2/N-mCherry-DEST 10 
(N-terminal tagged) by using Gateway cloning technology as described previously.8 A 11 
BLOCK-iT Pol II miR-RNAi expression vector kit (Invitrogen Corporation, K493500) was 12 
used to knockdown STX6, VAMP3, and VTI1B expression. We used the following targeting 13 
sequences: STX6, 5′-TACAAGTACTCGGCAAGTTGT-3′; VAMP3, 14 
5′-TGGCAGTAATCGAAGACTTCA-3′; and VTI1B, 15 
5′-GATGTCTAAGCTTCGAAACTA-3′. The miRNA double-strand sequences were ligated 16 
to pcDNA-6.2-GW/miR, as per supplier instructions; pcDNA6.2-GW/miR-neg was used as 17 
the miRNA control. These plasmids were transfected into HeLa cells as described above. 18 
Knockdowns were confirmed through immunoblotting. 19 
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Generation of knockout lines by using CRISPR/Cas9 gene editing 1 
We used the CRISPR/Cas9 system to generate STX6- and RABGEF1-knockout cell lines, as 2 
described previously.37 Briefly, CRISPR guide RNAs (gRNAs) were selected that targeted an 3 
exon common to all splicing variants of the gene of interest (STX6: 4 
ATGTCAACTTCATCTGTGC; RABGEF1: TCTCATCATCAGTAGTTTC). For 5 
CRISPR/Cas9 gene editing, HeLa cells were transfected with the gRNA-hyg vector 6 
containing CRISPR target sequences and hCAS917 (Addgene, 41815, George Church Lab). 7 
After the transfection step, untransfected cells were removed through selection with 300 8 
µg/mL hygromycin B and 750 µg/mL geneticin (G418) (both from Nacalai Tesque, 09287-84 9 
and 16513-26 respectively). Single colonies were expanded and the depletion of the targeted 10 
gene product was confirmed through immunoblotting. As a secondary screen of certain 11 
knockout lines, genomic DNA was isolated from cells and the genomic regions of interest 12 
were amplified using PCR. The targeted genomic regions of the knockout lines were also 13 
sequenced to confirm the presence of frameshifting indels in the genes of interest. 14 
Generation of cell lines with stable transgene expression  15 
Cell lines with stable transgene expression were generated by retroviral infection as 16 
previously described. Based on pLenti6/V5-DEST, the virus was produced using the 17 
ViraPower lentiviral expression system (Invitrogen Corporation, K4960-00) according to the 18 
manufacturer’s protocol. Briefly, 293 FT cells were cotransfected with pLenti-EmGFP-LC3 19 
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and the mixture of packaging plasmids (Invitrogen Corporation, K4975-00) using 1 
Lipofectamine 3000, and then cultured for 48 h. The viral supernatant was collected and used 2 
to infect HeLa cells. After 24 h, uninfected cells were removed by selection on 5 µg/mL 3 
blasticidin (Invitrogen Corporation, A1113903).  4 
Bacterial infection 5 
Cells were infected with GAS as described previously.6 Briefly, bacteria were incubated with 6 
cell cultures for 1 h at a multiplicity of infection of 100 in the absence of antibiotics. The 7 
infected cells were washed with phosphate-buffered saline (PBS; 137 mM NaCl, 2.7 mM KCl, 8 
8.1 mM Na2HPO4, 1.47 mM KH2PO4 [pH 7.4]) and the antibiotic gentamicin (100 µg/mL) 9 
was added for an appropriate period to kill extracellular bacteria. 10 
Fluorescence microscopy and image analyses 11 
For confocal microscopy analysis, cells were cultured on 12-mm-diameter glass coverslips in 12 
24-well culture plates. The cells were placed on a glass-bottom dish to facilitate time-lapse 13 
imaging. For immunostaining, cells were washed with PBS, fixed with 4% paraformaldehyde 14 
in PBS for 15 min, permeabilized with 0.1% Triton X-100 in PBS for 10 min, washed again 15 
with PBS, and then incubated in skim milk blocking buffer (5% skim milk/2.5% goat 16 
serum/2.5% donkey serum/0.1% gelatin/PBS) or BSA blocking buffer (2% BSA in PBS) at 17 
room temperature for 1 h. Subsequently, the cells were incubated (room temperature, 1 h) 18 
with primary antibodies diluted with blocking solution, washed with PBS, and then probed 19 
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with secondary antibodies. Bacterial and cellular DNAs were stained with 1 
4′,6-diamidino-2-phenylindole (DAPI) (Dojindo, D523). All fluorescence micrographs shown 2 
here are confocal images acquired using an FV1000 laser-scanning microscope (Olympus). 3 
For quantitative analysis, cell images were captured at random using the confocal microscope, 4 
and then colocalization was determined by calculating the Pearson’s coefficient after tracing 5 
individual cells by using ImageJ software (National Institutes of Health). 6 
Transferrin uptake 7 
Cells were incubated with 5 µg/mL Alexa-594-labelled human transferrin (Invitrogen 8 
Corporation, T13343) for 1 h at 37°C. Cells were washed with PBS and fixed, and the 9 
fluorescence intensity per cell was measured by confocal microscopy and ImageJ software. 10 
More than 10 randomly selected images were analyzed in each condition.  11 
Bacterial viability assay 12 
HeLa cells (4 × 104 cells/well) were cultured in 24-well culture plates and infected as 13 
described in “Bacterial infection.” After an appropriate incubation period, cells were lysed in 14 
sterile distilled water and serial dilutions of the lysates were plated on THY agar plates. The 15 
number of invaded and surviving GAS was determined through colony counting. The 16 
invasion data are presented as the ratio of total intracellular GAS at 2 h to total adhered and 17 
internalized GAS at 1 h, and the survival data are presented as the ratio of intracellular live 18 
GAS at 4 h to total intracellular GAS at 2 h. 19 
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Immunoprecipitation 1 
For immunoprecipitation, cells were harvested, washed with PBS, and lysed in a lysis buffer 2 
(10 mM Tris-HCl (pH 7.4), 150 mM NaCl, 10 mM MgCl2, 1 mM EDTA, and 1% Triton 3 
X-100) containing a proteinase inhibitor cocktail (Nacalai Tesque, 25955-11) for 30 min on 4 
ice. The lysates were centrifuged and the obtained supernatants were pre-cleared by 5 
incubating with Protein A Sepharose 4B (GE Healthcare Life Sciences, 17-1279-03) for 6 
30 min at 4°C. After brief centrifugation, the supernatants were reacted with anti-FLAG or 7 
anti-GFP antibodies for 2 h at 4°C, and then Protein A Sepharose beads were added and 8 
allowed to react (with rotation) for 1 h at 4°C. The immunoprecipitates were collected by 9 
briefly centrifuging the mixtures, washed 5 times with lysis buffer, and analyzed through 10 
immunoblotting. 11 
Statistical analysis 12 
Colocalization and GcAV formation were quantified through direct visualization performed 13 
using confocal microscopy. Unless indicated otherwise, at least 50 GcAVs or 200 14 
GAS-infected cells were counted per condition in each experiment, and at least 3 independent 15 
experiments were performed for each trial. Values, including those displayed in graphs, are 16 
means ± SD. Statistical analysis was performed using a two-tailed Student’s t test. P < 0.05 17 
was considered to indicate statistical significance; significance is marked as * for P < 0.05, ** 18 
for P < 0.01, *** for P < 0.001, and NS for not significant. 19 
20 
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Figure Legends 1 
Figure 1. STX6 localizes to TFRC-positive puncta on GcAVs. 2 
(A) A screen for syntaxin (STX) proteins that colocalize with GcAVs. HeLa cells expressing 3 
EmGFP-fused STX proteins and mCherry-fused LC3 (GcAV marker) were infected with GAS 4 
for 4 h and fixed. The percentages of EmGFP-STX-positive GcAVs were measured using 5 
confocal microscopy. (B) GcAV localization of endogenous STX6. HeLa cells expressing 6 
EmGFP-LC3 (green) were infected with GAS for 4 h and stained for STX6 (red). DAPI 7 
labels the nuclei and GAS (blue). The insets show high-magnification views of the area 8 
outlined in the main merged image. (C) HeLa cells expressing mCherry-LC3 and 9 
EmGFP-STX6 were infected with GAS for 2 h. (D) Colocalization of STX6 with GcAVs at 10 
different times post-infection. HeLa cells expressing mCherry-LC3 and EmGFP-STX6 were 11 
infected with GAS for the indicated times, and the percentages of EmGFP-STX-positive 12 
GcAVs were measured using confocal microscopy. (E) Colocalization of STX6 with TFRC 13 
and GcAVs. HeLa cells expressing EmGFP-STX6 were infected with GAS for 4 h and then 14 
immunostained for TFRC. Scale bars, 10 µm. (F) Pearson’s coefficient quantified for 15 
STX6/TFRC colocalization on GcAVs. Data represent means ± SD of >10 GcAVs analyzed 16 
per condition. (G) Merged image of the GcAV in (E). The graph shows the signal intensities 17 
of EmGFP-STX6 and TFRC measured along the red line in the GcAV image. Orange arrows 18 
indicate the signal peaks observed in both EmGFP-STX6 and TFRC. (H) Live-cell imaging 19 
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during GAS infection. HeLa cells expressing EmGFP-STX6 and mCherry-LC3 were infected 1 
with GAS for the indicated time points and images were captured by confocal microscopy. 2 
Scale bars, 3 µm. Data in (A) and (D) are means ± SD of 3 independent experiments. 3 
Figure 2. STX6 regulates the fusion between REs and GcAVs. 4 
(A) Immunoblotting analysis of STX6-knockdown HeLa cells. (B and C) HeLa cells 5 
transfected with control and STX6 miR vectors were infected with GAS for 4 h, fixed, and 6 
immunostained for TFRC. DAPI labels the nuclei and GAS. Representative confocal 7 
micrographs of GcAVs in control and STX6-knockdown (KD) HeLa cells (B), and 8 
quantification of TFRC-positive GcAVs (C). Yellow scale bars, 3 µm. (D) Immunoblotting 9 
analysis of STX6-knockout (KO) HeLa cells. (E and F) HeLa wild-type (WT) cells, 10 
STX6-KO cells, and STX6-KO cells expressing FLAG-STX6 were transfected with 11 
EmGFP-LC3 and infected with GAS for 4 h. Cells were fixed and immunostained for TFRC. 12 
Representative confocal micrographs of GcAVs in WT and STX6-KO HeLa cells (E), and 13 
quantification of TFRC-positive GcAVs (F). (G and H) HeLa WT and STX6-KO cells 14 
expressing EmGFP-LC3 were infected with GAS for 4 h. Representative confocal 15 
micrographs of the HeLa cells of each type (G), and quantification of GcAV-positive cells (H). 16 
(I) HeLa WT and STX6-KO cells were infected with GAS for 1, 2, and 4 h. The number of 17 
invaded and surviving bacteria was measured in the GAS viability assay. Data in (C), (F), (H), 18 
and (I) are means ± SD of 3 independent experiments. 19 
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Figure 3. VAMP3 and VTI1B interact with STX6 and promote the fusion between REs and 1 
GcAVs.  2 
(A–C) HeLa cells expressing EmGFP-SNARE proteins and mCherry-LC3 were infected with 3 
GAS for 4 h, fixed, and immunostained for TFRC. Pearson’s coefficient quantification of the 4 
colocalization of SNARE/LC3 or SNARE/TFRC on GcAVs (A), and representative confocal 5 
micrographs of VAMP3- and VTI1B-positive GcAVs (B, C). Data represent means ± SD of 6 
>10 GcAVs analyzed per condition. Scale bars, 10 µm. (D) STX6 interacts with VAMP3 and 7 
VTI1B. HeLa cells transfected with FLAG-STX6 and EmGFP (GFP), EmGFP-VAMP3, or 8 
EmGFP-VTI1B were either not infected or infected with GAS for 4 h, and then subjected to 9 
immunoprecipitations with an anti-GFP antibody. The immunoprecipitated proteins and total 10 
cell lysates were analyzed by immunoblotting with anti-FLAG and anti-GFP antibodies. (E) 11 
Immunoblotting analysis of VAMP3- and VTI1B-knockdown HeLa cells. (F and G) HeLa 12 
cells transfected with mCherry-LC3 and miR-control (Control), -VAMP3 (VAMP3 KD), or 13 
-VTI1B (VTI1B KD) were infected with GAS for 4 h and then fixed and immunostained for 14 
TFRC. Representative confocal micrographs of GcAVs in Control-, VAMP3 KD, and VTI1B 15 
KD HeLa cells (F), and Pearson’s coefficient quantification of the colocalization of 16 
LC3/TFRC on GcAVs (G). 17 
Figure 4. STX6 regions required for punctate localization on GcAVs, interaction with 18 
VAMP3 and VTI1B, and recruitment to GcAVs. 19 
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(A) Schematic map showing STX6 domain organization and deletion constructs used in this 1 
study. (B and C) HeLa cells transfected with EmGFP-STX6 constructs and mCherry-LC3 2 
were infected with GAS for 4 h. Pearson’s coefficient quantification of the colocalization of 3 
STX6 constructs/LC3 on GcAVs (B), and representative confocal micrographs of GcAVs (C). 4 
Scale bars, 10 µm. (D) HeLa cells expressing EmGFP-STX6ΔH2 and mCherry-LC3 were 5 
infected with GAS for 4 h and then immunostained for TFRC. The graph shows the signal 6 
intensities of EmGFP-STX6 and TFRC measured along the red line in the merged image. (E) 7 
STX6 H2 domain is required for interaction with VAMP3 and VTI1B. HeLa cells transfected 8 
with EmGFP-VAMP3 or -VTI1B and FLAG, FLAG-STX6, FLAG-STX6ΔH1, or 9 
FLAG-STX6ΔH2 were subjected to immunoprecipitations with an anti-FLAG antibody. The 10 
immunoprecipitated proteins and total cell lysates were analyzed by immunoblotting with 11 
anti-FLAG and anti-GFP antibodies. (F) HeLa STX6-KO cells expressing EmGFP-LC3 and 12 
FLAG-control, -STX6 FL, -STX6ΔH2, or -STX6ΔYGRL were infected with GAS for 4 h. 13 
The percentages of GcAV-positive cells were quantified using confocal microscopy. Data are 14 
the mean ± SD of 3 independent experiments.  15 
Figure 5. RABGEF1 is critical for the STX6-VAMP3 interaction and RE-GcAV fusion 16 
required to promote xenophagy. 17 
(A) Immunoblotting analysis of STX6-KO HeLa cells. (B–D) Involvement of RABGEF1 in 18 
RE recruitment and GcAV formation. HeLa WT and RABGEF1-KO cells were transfected 19 
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with EmGFP-LC3 and FLAG-RABGEF1, infected with GAS for 4 h, and then fixed and 1 
immunostained for TFRC. Representative confocal micrographs of each cell type (B), and 2 
quantification of TFRC-positive GcAVs (C) and GcAV-positive cells (D). (E and F) Effects of 3 
RABGEF1 KO on GcAV localization of STX6, VAMP3, and VTI1B. HeLa WT and 4 
RABGEF1-KO cells were transfected with mCherry-LC3 and EmGFP-STX6, -VAMP3, or 5 
-VTI1B, and then infected with GAS for 4 h. Representative confocal micrographs of each 6 
cell type (E), and Pearson’s coefficient quantification of colocalization on GcAVs (F). (G and 7 
H) RABGEF1 is required for the interaction between STX6 and VAMP3. HeLa WT and 8 
RABGEF1-KO cells were transfected with EmGFP-VAMP3 (G) or -VTI1B (H) and FLAG or 9 
FLAG-STX6, and subjected to immunoprecipitations with the anti-FLAG antibody. The 10 
immunoprecipitated proteins and total cell lysates were analyzed by immunoblotting with 11 
anti-FLAG and anti-GFP antibodies. 12 
Figure 6. STX6 but not RABGEF1 is involved in starvation-induced autophagosome 13 
formation. 14 
(A and B) WT and STX6 KO cells were cultured in regular or starvation medium for 2 h with 15 
or without E64d and pepstatin A, and analyzed by immunoblotting (A). The LC3-II level was 16 
quantified and normalized to that of actin (B). (C and D) WT and RABGEF1 KO cells were 17 
cultured in regular or starvation medium for 2 h with or without E64d and pepstatin A, and 18 
analyzed by immunoblotting (C). The LC3-II level was quantified and normalized to that of 19 
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actin (D). HeLa WT and STX6 KO cells stably expressing EGFP-LC3 were cultured in 1 
regular or starvation medium for 2 h. Confocal micrographs (E) and quantification of the 2 
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